Stericycle, Inc. (SRCL) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Stericycle, Inc. (NASDAQ:SRCL) announced its quarterly earnings data on Wednesday. The company reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The firm earned $906.40 million during the quarter, compared to analysts’ expectations of $902.62 million. During the same quarter last year, the business earned $1.11 earnings per share.
Shares of Stericycle (NASDAQ:SRCL) opened at 83.35 on Friday. Stericycle has a one year low of $71.52 and a one year high of $128.94. The firm has a market capitalization of $7.09 billion, a PE ratio of 30.30 and a beta of 0.08. The firm’s 50 day moving average is $78.20 and its 200-day moving average is $78.82.
“Stericycle, Inc. (SRCL) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS” was published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be accessed at http://www.dailypolitical.com/2017/02/16/stericycle-inc-srcl-releases-quarterly-earnings-results-beats-expectations-by-0-07-eps.html.
A number of equities analysts have issued reports on SRCL shares. RBC Capital Markets set a $74.00 target price on shares of Stericycle and gave the stock a “sell” rating in a research report on Saturday, January 21st. Jefferies Group LLC restated a “buy” rating and set a $108.00 target price on shares of Stericycle in a research report on Thursday. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, February 1st. Macquarie set a $100.00 target price on shares of Stericycle and gave the stock a “buy” rating in a research report on Monday, February 6th. Finally, Wedbush restated a “neutral” rating and set a $85.00 target price on shares of Stericycle in a research report on Wednesday, November 9th. Five analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $92.83.
In related news, Director Robert S. Murley purchased 1,000 shares of the stock in a transaction on Wednesday, February 1st. The shares were bought at an average price of $76.22 per share, for a total transaction of $76,220.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mark C. Miller sold 6,677 shares of the stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $76.23, for a total value of $508,987.71. Following the transaction, the director now owns 216,126 shares in the company, valued at approximately $16,475,284.98. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Capital Analysts LLC increased its stake in shares of Stericycle by 6.2% in the fourth quarter. Capital Analysts LLC now owns 1,294 shares of the company’s stock valued at $100,000 after buying an additional 76 shares during the last quarter. Pacad Investment Ltd. bought a new stake in shares of Stericycle during the fourth quarter valued at about $100,000. Balentine LLC increased its stake in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares during the last quarter. NEXT Financial Group Inc increased its stake in shares of Stericycle by 78.0% in the third quarter. NEXT Financial Group Inc now owns 1,620 shares of the company’s stock valued at $130,000 after buying an additional 710 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. bought a new stake in shares of Stericycle during the third quarter valued at about $136,000. Institutional investors and hedge funds own 94.49% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.